Screener
National Healthcare NHC Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by National Healthcare in its filing.
Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.
The source filing: National Healthcare’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 2:53 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-026199
FAQ
- What is National Healthcare's cash & equivalents?
- National Healthcare (NHC) reported cash & equivalents of $39.21M in Q2 2026.
- How has National Healthcare's cash & equivalents changed year-over-year?
- National Healthcare's cash & equivalents decreased by 64.7% year-over-year, from $110.99M to $39.21M.
- What is the long-term trend for National Healthcare's cash & equivalents?
- Over 5 years (2020 to 2025), National Healthcare's cash & equivalents has grown at a -8.8% compound annual growth rate (CAGR), from $147.09M to $92.83M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about National Healthcare's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude